Indication
Primary Open Angle Glaucoma of Both Eyes
3 clinical trials
6 products
Product
QLS-111Clinical trial
A Randomized, Multi-site, Double-masked Study Evaluating the Safety and Tolerability of QLS-111 vs Vehicle in Primary Open-angle Glaucoma or Ocular Hypertension PatientsStatus: Recruiting, Estimated PCD: 2024-09-05
Product
QLS-111 ophthalmic solutionClinical trial
An Open-label, Randomized, Controlled, Comparative Efficacy and Safety Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL (JGL dd, Croatia), vs. Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL (Merck Sharp & Dohme, France) in Patients With POAGStatus: Completed, Estimated PCD: 2018-09-17
Product
CosoptProduct
Dorzotimol eye dropsProduct
DorzolClinical trial
A Randomized, Open-label, Controlled, Comparative Study of Efficacy and Safety of Dorzol Eye Drops, 20 mg/mL (JGL dd, Croatia) vs Trusopt® Eye Drops, 20 mg/mL (Merck Sharp & Dohme, France) in Patients With Primary Open-angle GlaucomaStatus: Completed, Estimated PCD: 2017-04-05
Product
Trusopt